People News: Roche NimbleGen and ISI

Share this article:
Roche NimbleGen named Frank Pitzer CEO. Dr. Pitzer was previously head of divisional quality and regulatory affairs at Roche Diagnostics, reporting directly to the CEO, and was also a member of the Diagnostics executive committee.

ISI, a life sciences software company, named Lisa Jenkins, PhD director of regulatory strategy, responsible for advising clients on clinical development and global strategic regulatory affairs. Jenkins was previously associate director/regulatory group leader at Kendle International, and before that she was the principal statistician and senior manager of regulatory affairs at Wyeth.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

FDA reviews new painkiller

The candidate would be the first to put oxycodone and morphine in one capsule.

AbbVie's files all-oral HCV drug with FDA

AbbVie's all-oral HCV treatment filed off six Phase-III trials spanning 25 countries and 2,300 patients

Rumor: Pfizer offered to buy AstraZeneca

The rumored $101 billion bid would give Pfizer a foothold in imuno-oncology and diabetes.